Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial

1. Åbyholm, T.
2. Barlow, D.
3. Devroey, P.
4. Diedrich, K.
5. Donnez, J.
6. Von Düring, V.
7. Fauser, B.
8. Hamberger, L.
9. Hillensjö, T.
10. Hugues, J.N.
11. Jansen, C.
12. Kahn, J.
13. Blaabjerg, J.
14. Olivennes, F.
15. Pellicer, A.
16. Pavlou, S.
17. Rabe, T.
18. Rutherford, A.
19. Tarlatzis, B.
20. Westergaard, L.
21. Borm, G.
22. Mannaerts, B.